Trials / Recruiting
RecruitingNCT07036419
A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
A Clinical Study on Efficacy and Safety of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 3 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam Tosilate for injection | Remimazolam Tosilate for injection. |
| DRUG | Propofol Injection | Propofol injection. |
Timeline
- Start date
- 2025-07-10
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2025-06-25
- Last updated
- 2026-02-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07036419. Inclusion in this directory is not an endorsement.